SSG
Summit Securities Group Portfolio holdings
AUM
$280M
This Quarter Return
+5.14%
1 Year Return
+13.47%
3 Year Return
+33.41%
5 Year Return
+89.54%
10 Year Return
+225.55%
AUM
$361M
AUM Growth
+$361M
(-27%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-46.23%
Top 10 Holdings %
Top 10 Hldgs %
61.6%
Holding
1,215
New
180
Increased
284
Reduced
271
Closed
393
Top Buys
| 1 |
Microsoft
MSFT
|
$22.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
$18M |
| 3 |
Datadog
DDOG
|
$11.3M |
| 4 |
iShares China Large-Cap ETF
FXI
|
$11M |
| 5 |
Sanofi
SNY
|
$9.66M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$31.4M |
| 2 |
Cigna
CI
|
$19.4M |
| 3 |
FIVE9
FIVN
|
$17M |
| 4 |
Exxon Mobil
XOM
|
$16.6M |
| 5 |
Chevron
CVX
|
$13.2M |
Sector Composition
| 1 | Technology | 20.6% |
| 2 | Consumer Discretionary | 15.63% |
| 3 | Healthcare | 10.64% |
| 4 | Consumer Staples | 6.64% |
| 5 | Communication Services | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Johnson & Johnson
JNJ
$429B
| $605K | 0.05% |
3,906
-3,164
| -45% | -$490K |
|
52
Mastercard
MA
$536B
| $602K | 0.05% |
1,656
-65
| -4% | -$23.6K |
|
53
JPMorgan Chase
JPM
$824B
| $590K | 0.05% |
4,531
-10,264
| -69% | -$1.34M |
|
54
Petrobras
PBR
$79.3B
| $552K | 0.05% |
52,887
-121,254
| -70% | -$1.27M |
|
55
Procter & Gamble
PG
$370B
| $551K | 0.05% |
3,706
-4,397
| -54% | -$654K |
|
56
Lockheed Martin
LMT
$105B
| $541K | 0.04% |
1,144
-5,408
| -83% | -$2.56M |
|
57
Bristol-Myers Squibb
BMY
$96.7B
| $539K | 0.04% |
7,770
-43,459
| -85% | -$3.01M |
|
|
58
Chevron
CVX
$318B
| $533K | 0.04% |
3,267
-80,931
| -96% | -$13.2M |
|
59
Eli Lilly
LLY
$661B
| $531K | 0.04% |
1,547
-69
| -4% | -$23.7K |
|
60
Marvell Technology
MRVL
$53.7B
| $494K | 0.04% |
11,400
-4,600
| -29% | -$199K |
|
61
TSMC
TSM
$1.2T
| $493K | 0.04% |
5,300
-9,300
| -64% | -$865K |
|
62
Frontline
FRO
$4.86B
| $485K | 0.04% |
+29,300
| New | +$485K |
|
63
Gilead Sciences
GILD
$140B
| $481K | 0.04% |
5,800
-65,100
| -92% | -$5.4M |
|
64
Thermo Fisher Scientific
TMO
$183B
| $444K | 0.04% |
770
+370
| +93% | +$213K |
|
65
Visa
V
$681B
| $443K | 0.04% |
1,964
+81
| +4% | +$18.3K |
|
66
Warner Bros
WBD
$29.5B
| $434K | 0.04% |
28,734
+4,262
| +17% | +$64.4K |
|
|
PXD
67
DELISTED
Pioneer Natural Resource Co.
PXD
| $422K | 0.03% |
2,067
+1,128
| +120% | +$230K |
|
68
Qiagen
QGEN
$10.1B
| $413K | 0.03% |
+9,000
| New | +$413K |
|
69
B&G Foods
BGS
$356M
| $404K | 0.03% |
26,000
-18,274
| -41% | -$284K |
|
70
Occidental Petroleum Corporation Warrants to Purchase Common Stock
OXY.WS
$23B
| $403K | 0.03% |
9,839
-1,700
| -15% | -$69.6K |
|
71
Coca-Cola
KO
$297B
| $398K | 0.03% |
6,411
-1,853
| -22% | -$115K |
|
72
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$264M
| $393K | 0.03% |
8,750
-31,250
| -78% | -$56K |
|
73
RTX Corp
RTX
$212B
| $389K | 0.03% |
3,974
-3,286
| -45% | -$322K |
|
74
W.P. Carey
WPC
$14.6B
| $356K | 0.03% |
4,600
-200
| -4% | -$15.5K |
|
75
Accenture
ACN
$158B
| $353K | 0.03% |
1,234
-829
| -40% | -$237K |
|